Table I.
Clinical Parameters of HIV-1–infected, Statin-treated Patients
Patient ID | 1 | 2 | 3 | 4 | 5 | 6 | |
---|---|---|---|---|---|---|---|
Sex | Male | Male | Female | Male | Male | Male | |
Age | 53 | 23 | 33 | 24 | 42 | 39 | |
Virus transmission | Sexual | Sexual | IVDUa | Sexual | IVDU | IVDU | |
Diagnosis date | 1997 | 2000 | 1996 | ND | 1998 | 1996 | |
HAART | No | No | No | No | No | No | |
HCVb coinfection | No | No | Yes | No | Yes | Yes | |
Other | Ethylism, pancreatitis |
Asthma | Methadone treatment |
No | Methadone treatment |
Methadone treatment |
|
Viral loadc | Before | 16,800 | 19,500 | 50,100 | 84,000 | 37,300 | 46,400 |
After | 2,330 | 9,940 | 12,138 | 3,590 | 21,600 | 26,300 | |
Reboundd | 16,100 | 56,100 | 64,000 | 26,400 | 26,400 | 32,600 | |
CD4+ (count/ml) | Before | 798 | 520 | 513 | 760 | 465 | 538 |
After | 940 | 560 | 540 | 1,010 | 487 | 552 | |
Rebound | 690 | 550 | 501 | 501 | 478 | 560 |
Intravenous drug use.
Hepatitis C virus.
Viral load is expressed as HIV-1 RNA copies/ml.
Measurements after 3 mo without treatment.